FDA Guidance on CT Mgmt during COVID-19

Health Care, Pharma Industry, Strategic Planning

FDA issued this guidance to provide general considerations to assist sponsors in assuring the safety of trial participants, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 pandemic.

Read the Guidance now

Related Education Resources.

All Resources

Dave Mitchell Webinar Series

Topics: Communication, Leadership, Personal Development, Team Building

Webinar

Members

EAP 102: Part 2 of Introduction to EAP

Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning, Project Management, Strategic Planning

Presentation

Members

EMA Guidance on Trial Mgmt during COVID-19

Topics: Health Care, Pharma Industry, Strategic Planning

Guidance Document

Free

Become a member

Global Clinical Supplies Group

Join GCSG for full access...

to our educational resources, conference materials and our directory of more than 480 Clinical Supply colleagues. Experience the culture of collaboration, It only takes approximately 3 minutes 22 seconds.

Please note that membership is included and FREE of charge when you sign up for an event.

Join Renew